Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUGT1P1 is classified as a pseudogene of the SUGT1 gene. Pseudogenes are DNA segments that resemble functional genes but are generally non-functional due to mutations, truncations, or lack of regulatory elements. SUGT1P1 does not encode a functional protein and does not act as a receptor, enzyme, transporter, or other therapeutic target. It is not associated with known biological functions, disease roles, drug interactions, mechanisms of action, or safety concerns relevant to drug discovery or clinical development. The parent gene, SUGT1, does play important roles in cell cycle regulation, kinetochore assembly, and has some relevance as a biomarker in cancer, but SUGT1P1 itself is merely a genomic relic without direct biological activity[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SUGT1 pseudogene 1 (SUGT1P1).